Expanding Opportunities for Patients to Be Treated with Immune Checkpoint Inhibition:...
By Jarushka Naidoo, MB, BCH
Posted: April 1, 2019
The U.S. Food and Drug Administration (FDA) has approved immune checkpoint inhibitors for multiple cancer types, including stage...
PACIFIC Flooded Us with Optimism. Now What?
By Mirjana Rajer, MD, PhD
Posted: April 1, 2019
For many years, the treatment of patients with stage III lung cancer has been a topic of intense...
Advocacy & Survivorship
Improving Clinical Trials Through Clinician, Patient Use of Social Media
By DR Camidge
Posted: March 1, 2019
The National Cancer Institute featured a workshop in June 2018 titled “At the Crossroads of Social Media and Clinical...
Meeting News
Mentorship and Travel Awards for Nursing and Allied Health at WCLC...
By Erik MacLaren, PhD
Posted: April 1, 2019
In September 2018, several attendees of the 19th World Conference on Lung Cancer (WCLC) in Toronto, Canada, received Travel...
